The stock of Vigil Neuroscience Inc (VIGL) has seen a -10.21% decrease in the past week, with a -20.38% drop in the past month, and a -7.05% decrease in the past quarter. The volatility ratio for the week is 9.91%, and the volatility levels for the past 30 days are at 8.67% for VIGL. The simple moving average for the past 20 days is -16.71% for VIGL’s stock, with a -33.06% simple moving average for the past 200 days.
Is It Worth Investing in Vigil Neuroscience Inc (NASDAQ: VIGL) Right Now?
The 36-month beta value for VIGL is also noteworthy at 1.78. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 1 rating it as “sell.”
The public float for VIGL is 19.81M, and at present, short sellers hold a 2.85% of that float. The average trading volume of VIGL on March 14, 2025 was 1.11M shares.
VIGL) stock’s latest price update
The stock of Vigil Neuroscience Inc (NASDAQ: VIGL) has decreased by -10.21 when compared to last closing price of 2.35.Despite this, the company has seen a loss of -10.21% in its stock price over the last five trading days. globenewswire.com reported 2025-03-13 that – Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer’s Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 –
Analysts’ Opinion of VIGL
Morgan Stanley, on the other hand, stated in their research note that they expect to see VIGL reach a price target of $4, previously predicting the price at $13. The rating they have provided for VIGL stocks is “Underweight” according to the report published on December 19th, 2023.
JMP Securities gave a rating of “Mkt Outperform” to VIGL, setting the target price at $23 in the report published on October 18th of the previous year.
VIGL Trading at -8.46% from the 50-Day Moving Average
After a stumble in the market that brought VIGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.18% of loss for the given period.
Volatility was left at 8.67%, however, over the last 30 days, the volatility rate increased by 9.91%, as shares sank -21.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +27.88% upper at present.
During the last 5 trading sessions, VIGL fell by -10.21%, which changed the moving average for the period of 200-days by -41.23% in comparison to the 20-day moving average, which settled at $2.53. In addition, Vigil Neuroscience Inc saw 24.12% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VIGL starting from Budd Haeberlein Samantha L., who purchase 12,000 shares at the price of $1.71 back on Dec 19 ’24. After this action, Budd Haeberlein Samantha L. now owns 12,000 shares of Vigil Neuroscience Inc, valued at $20,520 using the latest closing price.
Magovcevic-Liebisch Ivana, the President and CEO of Vigil Neuroscience Inc, purchase 5,000 shares at $1.68 during a trade that took place back on Dec 19 ’24, which means that Magovcevic-Liebisch Ivana is holding 222,687 shares at $8,400 based on the most recent closing price.
Stock Fundamentals for VIGL
Current profitability levels for the company are sitting at:
- -45.72 for the present operating margin
- 0.82 for the gross margin
The net margin for Vigil Neuroscience Inc stands at -42.71. The total capital return value is set at -0.88. Equity return is now at value -73.62, with -56.88 for asset returns.
Based on Vigil Neuroscience Inc (VIGL), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -3.69. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -84.62.
Currently, EBITDA for the company is -88.47 million with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of 28.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.72.
Conclusion
In summary, Vigil Neuroscience Inc (VIGL) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
